| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF410 ZNF672 ZNF48 SALL3 FOXP2 ZNF337 ZNF875 ZNF184 ZNF316 ETV2 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZNF776 BHLHE23 ZNF497 ZNF718 GLI4 NFX1 ZNF84 ZFP92 ZNF30 ZNF697 | 5.15e-09 | 1459 | 98 | 26 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF672 ZNF48 SALL3 FOXP2 ZNF337 ZNF875 ZNF184 ZNF316 ETV2 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZNF776 BHLHE23 ZNF718 GLI4 NFX1 ZNF84 ZFP92 ZNF30 NOTCH4 ZNF697 | 1.25e-08 | 1412 | 98 | 25 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF410 ZNF48 SALL3 FOXP2 ZNF184 ZNF316 ETV2 ZNF213 ZNF275 ZNF467 GFI1 ZNF786 ZNF776 BHLHE23 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 NOTCH4 ZNF697 | 1.68e-07 | 1271 | 98 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF410 ZNF48 SALL3 FOXP2 ZNF184 ZNF316 ETV2 ZNF213 ZNF275 ZNF467 GFI1 ZNF786 ZNF776 BHLHE23 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 5.13e-07 | 1244 | 98 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.06e-06 | 188 | 98 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor | 2.38e-05 | 2 | 98 | 2 | GO:0046857 | |
| GeneOntologyMolecularFunction | GMP reductase activity | 2.38e-05 | 2 | 98 | 2 | GO:0003920 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA ligase activity | 7.13e-05 | 3 | 98 | 2 | GO:0090433 | |
| GeneOntologyMolecularFunction | calcium ion binding | TENM2 STAB1 THBS3 FAT1 CELSR2 MEGF8 LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 1.11e-03 | 749 | 98 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 1.27e-03 | 11 | 98 | 2 | GO:0047676 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A6 PRTN3 FN1 TNC ACTA2 LAMB3 LAMC1 LAMC3 THBS3 FCGBP CLEC14A LPA PLG VWA2 MUC5AC FBN3 | 6.41e-08 | 656 | 98 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A6 PRTN3 FN1 TNC ACTA2 LAMB3 LAMC1 LAMC3 THBS3 FCGBP CLEC14A LPA PLG VWA2 MUC5AC FBN3 | 6.68e-08 | 658 | 98 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 1.08e-07 | 122 | 98 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A6 PRTN3 FN1 TNC ACTA2 LAMB3 LAMC1 LAMC3 THBS3 CLEC14A LPA PLG VWA2 | 1.16e-06 | 530 | 98 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | GMP reductase complex | 2.18e-05 | 2 | 98 | 2 | GO:1902560 | |
| GeneOntologyCellularComponent | laminin complex | 9.55e-04 | 10 | 98 | 2 | GO:0043256 | |
| MousePheno | abnormal conjunctival epithelium morphology | 5.11e-06 | 7 | 75 | 3 | MP:0004481 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 2.84e-05 | 2 | 75 | 2 | MP:0009507 | |
| MousePheno | ectropion | 2.84e-05 | 2 | 75 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 2.84e-05 | 2 | 75 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 2.84e-05 | 2 | 75 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 2.84e-05 | 2 | 75 | 2 | MP:0005035 | |
| MousePheno | abnormal conjunctiva morphology | 4.08e-05 | 13 | 75 | 3 | MP:0001310 | |
| MousePheno | absent cornea epithelium | 8.49e-05 | 3 | 75 | 2 | MP:0020856 | |
| MousePheno | increased circulating fibrinogen level | 1.69e-04 | 4 | 75 | 2 | MP:0012331 | |
| MousePheno | proctitis | 1.69e-04 | 4 | 75 | 2 | MP:0003305 | |
| Domain | EGF_1 | FN1 TNC LAMB3 LAMC1 LAMC3 TENM2 STAB1 THBS3 FAT1 CELSR2 MEGF8 CLEC14A LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 1.67e-14 | 255 | 97 | 17 | PS00022 |
| Domain | EGF-like_CS | FN1 TNC LAMB3 LAMC1 LAMC3 TENM2 STAB1 THBS3 FAT1 CELSR2 MEGF8 CLEC14A LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 2.44e-14 | 261 | 97 | 17 | IPR013032 |
| Domain | EGF | TNC LAMC1 LAMC3 TENM2 STAB1 THBS3 FAT1 FCGBP CELSR2 MEGF8 CLEC14A LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 7.60e-14 | 235 | 97 | 16 | SM00181 |
| Domain | zf-C2H2 | ZNF410 ZNF672 ZNF48 SALL3 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 8.46e-14 | 693 | 97 | 24 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF410 ZNF672 ZNF48 SALL3 FOXP2 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 1.15e-13 | 775 | 97 | 25 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF410 ZNF672 ZNF48 SALL3 FOXP2 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 1.22e-13 | 777 | 97 | 25 | PS00028 |
| Domain | EGF-like_dom | TNC LAMC1 LAMC3 TENM2 STAB1 THBS3 FAT1 FCGBP CELSR2 MEGF8 CLEC14A LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 1.86e-13 | 249 | 97 | 16 | IPR000742 |
| Domain | Znf_C2H2 | ZNF410 ZNF672 ZNF48 SALL3 FOXP2 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 2.68e-13 | 805 | 97 | 25 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF410 ZNF672 ZNF48 SALL3 FOXP2 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 2.91e-13 | 808 | 97 | 25 | SM00355 |
| Domain | - | ZNF410 ZNF672 ZNF48 SALL3 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 4.84e-13 | 679 | 97 | 23 | 3.30.160.60 |
| Domain | EGF_2 | TNC LAMB3 LAMC1 LAMC3 TENM2 STAB1 THBS3 FAT1 CELSR2 MEGF8 CLEC14A LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 4.87e-13 | 265 | 97 | 16 | PS01186 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF410 ZNF672 ZNF48 SALL3 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 7.61e-13 | 694 | 97 | 23 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF410 ZNF672 ZNF48 SALL3 FOXP2 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 1.66e-12 | 796 | 97 | 24 | IPR015880 |
| Domain | Growth_fac_rcpt_ | TNC LAMC1 LAMC3 STAB1 THBS3 FAT1 CELSR2 MEGF8 LRP2 FBN3 NOTCH3 NOTCH4 | 2.91e-11 | 156 | 97 | 12 | IPR009030 |
| Domain | EGF_CA | TENM2 STAB1 THBS3 FAT1 CELSR2 MEGF8 LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 3.62e-11 | 122 | 97 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | TENM2 STAB1 THBS3 FAT1 CELSR2 MEGF8 LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 4.33e-11 | 124 | 97 | 11 | IPR001881 |
| Domain | EGF_3 | TNC TENM2 STAB1 THBS3 FAT1 CELSR2 MEGF8 CLEC14A LRP2 VWA2 FBN3 NOTCH3 NOTCH4 | 2.60e-10 | 235 | 97 | 13 | PS50026 |
| Domain | EGF_LAM_2 | 9.01e-09 | 30 | 97 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 9.01e-09 | 30 | 97 | 6 | PS01248 | |
| Domain | EGF | 1.88e-08 | 126 | 97 | 9 | PF00008 | |
| Domain | Laminin_EGF | 2.41e-08 | 35 | 97 | 6 | PF00053 | |
| Domain | EGF_Lam | 2.41e-08 | 35 | 97 | 6 | SM00180 | |
| Domain | Laminin_EGF | 4.05e-08 | 38 | 97 | 6 | IPR002049 | |
| Domain | ASX_HYDROXYL | 4.96e-08 | 100 | 97 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.84e-08 | 106 | 97 | 8 | IPR000152 | |
| Domain | zf-C2H2_6 | ZNF672 ZNF48 ZNF184 ZNF316 ZNF619 ZNF467 GFI1 ZNF497 ZNF718 ZNF84 ZFP92 ZNF30 | 8.23e-08 | 314 | 97 | 12 | PF13912 |
| Domain | EGF_CA | 3.15e-07 | 86 | 97 | 7 | PF07645 | |
| Domain | KRAB | ZNF337 ZNF875 ZNF184 ZNF316 ZNF213 ZNF275 ZNF786 ZNF776 ZNF718 ZNF84 ZFP92 ZNF30 | 3.38e-07 | 358 | 97 | 12 | PS50805 |
| Domain | KRAB | ZNF337 ZNF875 ZNF184 ZNF316 ZNF213 ZNF275 ZNF786 ZNF776 ZNF718 ZNF84 ZFP92 ZNF30 | 3.38e-07 | 358 | 97 | 12 | PF01352 |
| Domain | KRAB | ZNF337 ZNF875 ZNF184 ZNF316 ZNF213 ZNF275 ZNF786 ZNF776 ZNF718 ZNF84 ZFP92 ZNF30 | 4.67e-07 | 369 | 97 | 12 | SM00349 |
| Domain | KRAB | ZNF337 ZNF875 ZNF184 ZNF316 ZNF213 ZNF275 ZNF786 ZNF776 ZNF718 ZNF84 ZFP92 ZNF30 | 4.80e-07 | 370 | 97 | 12 | IPR001909 |
| Domain | TIL_dom | 6.58e-07 | 14 | 97 | 4 | IPR002919 | |
| Domain | EGF_Ca-bd_CS | 7.18e-07 | 97 | 97 | 7 | IPR018097 | |
| Domain | EGF_CA | 8.25e-07 | 99 | 97 | 7 | PS01187 | |
| Domain | hEGF | 1.27e-05 | 28 | 97 | 4 | PF12661 | |
| Domain | GMPR | 2.67e-05 | 2 | 97 | 2 | IPR005993 | |
| Domain | Unchr_dom_Cys-rich | 3.74e-05 | 13 | 97 | 3 | IPR014853 | |
| Domain | C8 | 3.74e-05 | 13 | 97 | 3 | SM00832 | |
| Domain | VWD | 7.24e-05 | 16 | 97 | 3 | SM00216 | |
| Domain | VWF_type-D | 7.24e-05 | 16 | 97 | 3 | IPR001846 | |
| Domain | Laminin_N | 7.24e-05 | 16 | 97 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 7.24e-05 | 16 | 97 | 3 | PS51117 | |
| Domain | VWFD | 7.24e-05 | 16 | 97 | 3 | PS51233 | |
| Domain | Laminin_N | 7.24e-05 | 16 | 97 | 3 | PF00055 | |
| Domain | VWD | 7.24e-05 | 16 | 97 | 3 | PF00094 | |
| Domain | LamNT | 7.24e-05 | 16 | 97 | 3 | SM00136 | |
| Domain | VWC_out | 1.24e-04 | 19 | 97 | 3 | SM00215 | |
| Domain | Notch | 1.59e-04 | 4 | 97 | 2 | IPR008297 | |
| Domain | NODP | 1.59e-04 | 4 | 97 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.59e-04 | 4 | 97 | 2 | IPR011656 | |
| Domain | IMPDH | 1.59e-04 | 4 | 97 | 2 | PF00478 | |
| Domain | Notch_NOD_dom | 1.59e-04 | 4 | 97 | 2 | IPR010660 | |
| Domain | IMP_DH_GMPRt | 1.59e-04 | 4 | 97 | 2 | IPR001093 | |
| Domain | NOD | 1.59e-04 | 4 | 97 | 2 | PF06816 | |
| Domain | IMP_DH_GMP_RED | 1.59e-04 | 4 | 97 | 2 | PS00487 | |
| Domain | NOD | 1.59e-04 | 4 | 97 | 2 | SM01338 | |
| Domain | NODP | 1.59e-04 | 4 | 97 | 2 | SM01339 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 1.59e-04 | 4 | 97 | 2 | IPR015875 | |
| Domain | TRYPSIN_SER | 2.28e-04 | 106 | 97 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.38e-04 | 107 | 97 | 5 | PS00134 | |
| Domain | LNR | 2.64e-04 | 5 | 97 | 2 | PS50258 | |
| Domain | EGF_extracell | 2.67e-04 | 60 | 97 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.67e-04 | 60 | 97 | 4 | PF07974 | |
| Domain | Peptidase_S1A | 3.07e-04 | 113 | 97 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 3.33e-04 | 115 | 97 | 5 | PS50240 | |
| Domain | Tryp_SPc | 3.61e-04 | 117 | 97 | 5 | SM00020 | |
| Domain | Trypsin | 4.21e-04 | 121 | 97 | 5 | PF00089 | |
| Domain | Trypsin_dom | 4.21e-04 | 121 | 97 | 5 | IPR001254 | |
| Domain | Peptidase_S1_PA | 4.54e-04 | 123 | 97 | 5 | IPR009003 | |
| Domain | Notch_dom | 5.51e-04 | 7 | 97 | 2 | IPR000800 | |
| Domain | Notch | 5.51e-04 | 7 | 97 | 2 | PF00066 | |
| Domain | NL | 5.51e-04 | 7 | 97 | 2 | SM00004 | |
| Domain | Kringle-like | 6.04e-04 | 32 | 97 | 3 | IPR013806 | |
| Domain | LAMININ_IVA | 7.32e-04 | 8 | 97 | 2 | PS51115 | |
| Domain | Laminin_B | 7.32e-04 | 8 | 97 | 2 | PF00052 | |
| Domain | LamB | 7.32e-04 | 8 | 97 | 2 | SM00281 | |
| Domain | Laminin_IV | 7.32e-04 | 8 | 97 | 2 | IPR000034 | |
| Domain | VWC | 1.00e-03 | 38 | 97 | 3 | SM00214 | |
| Domain | VWF_dom | 1.35e-03 | 42 | 97 | 3 | IPR001007 | |
| Domain | EGF_3 | 1.70e-03 | 12 | 97 | 2 | PF12947 | |
| Domain | TIL | 1.70e-03 | 12 | 97 | 2 | PF01826 | |
| Domain | EGF_dom | 1.70e-03 | 12 | 97 | 2 | IPR024731 | |
| Domain | C8 | 1.70e-03 | 12 | 97 | 2 | PF08742 | |
| Domain | TRYPSIN_HIS | 2.04e-03 | 103 | 97 | 4 | IPR018114 | |
| Domain | Kelch-typ_b-propeller | 2.93e-03 | 55 | 97 | 3 | IPR015915 | |
| Domain | Laminin_G | 3.41e-03 | 58 | 97 | 3 | IPR001791 | |
| Domain | Kringle | 3.45e-03 | 17 | 97 | 2 | IPR000001 | |
| Domain | Kringle_CS | 3.45e-03 | 17 | 97 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 3.45e-03 | 17 | 97 | 2 | PS50070 | |
| Domain | Kringle | 3.45e-03 | 17 | 97 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 3.45e-03 | 17 | 97 | 2 | PS00021 | |
| Domain | KR | 3.45e-03 | 17 | 97 | 2 | SM00130 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.58e-03 | 59 | 97 | 3 | IPR011043 | |
| Domain | Apc4_WD40_dom | 4.77e-03 | 20 | 97 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.77e-03 | 20 | 97 | 2 | PF12894 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.21e-07 | 84 | 66 | 7 | M7098 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.10e-07 | 59 | 66 | 6 | M27218 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.55e-06 | 84 | 66 | 6 | M3228 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.57e-06 | 96 | 66 | 6 | M39834 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.10e-05 | 30 | 66 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.10e-05 | 30 | 66 | 4 | M27216 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.38e-05 | 66 | 66 | 5 | M18 | |
| Pathway | WP_FOCAL_ADHESION | 2.60e-05 | 187 | 66 | 7 | MM15913 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.71e-05 | 13 | 66 | 3 | M47534 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.44e-05 | 14 | 66 | 3 | MM1458 | |
| Pathway | WP_FOCAL_ADHESION | 3.87e-05 | 199 | 66 | 7 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.87e-05 | 199 | 66 | 7 | M7253 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.90e-05 | 41 | 66 | 4 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.71e-05 | 43 | 66 | 4 | M53 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.80e-05 | 140 | 66 | 6 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.54e-05 | 300 | 66 | 8 | M610 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 1.62e-04 | 23 | 66 | 3 | M27831 | |
| Pathway | REACTOME_NUCLEOTIDE_SALVAGE | 1.62e-04 | 23 | 66 | 3 | MM15552 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.14e-04 | 5 | 66 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.14e-04 | 5 | 66 | 2 | MM14733 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 3.20e-04 | 6 | 66 | 2 | M27068 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.64e-04 | 30 | 66 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.64e-04 | 30 | 66 | 3 | MM15812 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.37e-04 | 76 | 66 | 4 | M27219 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 4.41e-04 | 32 | 66 | 3 | M165 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.47e-04 | 7 | 66 | 2 | MM14734 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.06e-04 | 79 | 66 | 4 | M27643 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.10e-04 | 302 | 66 | 7 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.02e-04 | 326 | 66 | 7 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.01e-03 | 339 | 66 | 7 | M39736 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.16e-03 | 11 | 66 | 2 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.16e-03 | 11 | 66 | 2 | MM15035 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.16e-03 | 11 | 66 | 2 | M158 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.16e-03 | 11 | 66 | 2 | M47865 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS | 1.16e-03 | 11 | 66 | 2 | M47626 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.29e-03 | 46 | 66 | 3 | M239 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 1.37e-03 | 47 | 66 | 3 | M39853 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.38e-03 | 12 | 66 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.38e-03 | 12 | 66 | 2 | M47533 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 1.38e-03 | 12 | 66 | 2 | MM1398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.63e-03 | 13 | 66 | 2 | M47423 | |
| Pathway | REACTOME_PURINE_SALVAGE | 1.63e-03 | 13 | 66 | 2 | MM15438 | |
| Pathway | REACTOME_PURINE_SALVAGE | 1.63e-03 | 13 | 66 | 2 | M814 | |
| Pathway | WP_THERMOGENESIS | 1.63e-03 | 108 | 66 | 4 | M39746 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 1.84e-03 | 52 | 66 | 3 | MM15920 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 1.89e-03 | 14 | 66 | 2 | M39780 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.89e-03 | 14 | 66 | 2 | M6487 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 1.89e-03 | 14 | 66 | 2 | MM15840 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.99e-03 | 114 | 66 | 4 | MM14571 | |
| Pathway | WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS | 2.18e-03 | 15 | 66 | 2 | M39789 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.18e-03 | 15 | 66 | 2 | M27161 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 2.18e-03 | 15 | 66 | 2 | MM15450 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.39e-03 | 57 | 66 | 3 | MM14713 | |
| Pathway | WP_CANCER_PATHWAYS | 2.43e-03 | 507 | 66 | 8 | M48302 | |
| Pathway | WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION | 2.48e-03 | 16 | 66 | 2 | MM15841 | |
| Pathway | WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS | 2.48e-03 | 16 | 66 | 2 | MM15813 | |
| Pathway | WP_BDNF_PATHWAY | 2.48e-03 | 16 | 66 | 2 | MM15816 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.70e-03 | 124 | 66 | 4 | M27285 | |
| Pathway | WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION | 2.81e-03 | 17 | 66 | 2 | M39365 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.15e-03 | 18 | 66 | 2 | M614 | |
| Pathway | WP_FATTY_ACID_TRANSPORTERS | 3.15e-03 | 18 | 66 | 2 | M42570 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 3.51e-03 | 19 | 66 | 2 | M39370 | |
| Pathway | WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS | 3.51e-03 | 19 | 66 | 2 | M48049 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.88e-03 | 20 | 66 | 2 | M27881 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 3.88e-03 | 20 | 66 | 2 | M15394 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.95e-03 | 68 | 66 | 3 | M27303 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.08e-03 | 325 | 66 | 6 | M12868 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 4.33e-03 | 439 | 66 | 7 | M42563 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 4.69e-03 | 22 | 66 | 2 | M39440 | |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 4.69e-03 | 22 | 66 | 2 | MM15451 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.13e-03 | 23 | 66 | 2 | MM14954 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 5.13e-03 | 23 | 66 | 2 | MM15885 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 5.13e-03 | 23 | 66 | 2 | MM15936 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.40e-03 | 76 | 66 | 3 | MM14867 | |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 5.58e-03 | 24 | 66 | 2 | M1016 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 5.58e-03 | 24 | 66 | 2 | M11190 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 6.04e-03 | 25 | 66 | 2 | M118 | |
| Pubmed | 1.11e-08 | 26 | 100 | 5 | 24742657 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 24791857 | ||
| Pubmed | 3.05e-08 | 167 | 100 | 8 | 22159717 | ||
| Pubmed | 8.57e-08 | 15 | 100 | 4 | 38537630 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 1.91e-07 | 18 | 100 | 4 | 23041440 | |
| Pubmed | 1.91e-07 | 18 | 100 | 4 | 11311202 | ||
| Pubmed | 4.52e-07 | 22 | 100 | 4 | 34998785 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 4.58e-07 | 6 | 100 | 3 | 12244553 | |
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 6.54e-07 | 24 | 100 | 4 | 26552887 | |
| Pubmed | Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. | 8.01e-07 | 7 | 100 | 3 | 11344305 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 9.16e-07 | 26 | 100 | 4 | 34189436 | |
| Pubmed | 9.80e-07 | 181 | 100 | 7 | 37372979 | ||
| Pubmed | The basement membrane of hair follicle stem cells is a muscle cell niche. | 1.25e-06 | 28 | 100 | 4 | 21335239 | |
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 1.91e-06 | 31 | 100 | 4 | 11431694 | |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 9827803 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 22688677 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 3.74e-06 | 11 | 100 | 3 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 3.74e-06 | 11 | 100 | 3 | 23472759 | |
| Pubmed | Sterile Inflammation Enhances ECM Degradation in Integrin β1 KO Embryonic Skin. | 4.41e-06 | 38 | 100 | 4 | 27653694 | |
| Pubmed | Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels. | 4.98e-06 | 12 | 100 | 3 | 33934370 | |
| Pubmed | 5.57e-06 | 153 | 100 | 6 | 25037231 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 6.46e-06 | 13 | 100 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 6.46e-06 | 13 | 100 | 3 | 20558824 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PRTN3 REXO5 FN1 LAMC1 GDF2 ACSL4 FAT1 FCGBP CSE1L EML5 MEGF8 OSBPL1A LRP2 | 7.11e-06 | 1016 | 100 | 13 | 19056867 |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31690812 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30254165 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 8.18e-06 | 2 | 100 | 2 | 9819364 | |
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 8.18e-06 | 2 | 100 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 8.18e-06 | 2 | 100 | 2 | 23943648 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12083480 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35141985 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 8.18e-06 | 2 | 100 | 2 | 18420257 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 8.18e-06 | 2 | 100 | 2 | 7705657 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23041318 | ||
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 8.18e-06 | 2 | 100 | 2 | 18566672 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19752236 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 6216475 | ||
| Pubmed | Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. | 8.18e-06 | 2 | 100 | 2 | 33665264 | |
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 8.18e-06 | 2 | 100 | 2 | 20653841 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12428098 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23341464 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 8.18e-06 | 2 | 100 | 2 | 20440070 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21496259 | ||
| Pubmed | Rotavirus enterotoxin NSP4 binds to the extracellular matrix proteins laminin-beta3 and fibronectin. | 8.18e-06 | 2 | 100 | 2 | 15331737 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24732409 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 8.18e-06 | 2 | 100 | 2 | 15456492 | |
| Pubmed | Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. | 8.18e-06 | 2 | 100 | 2 | 30451798 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 8.18e-06 | 2 | 100 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 8.18e-06 | 2 | 100 | 2 | 16956791 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25409527 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 1543918 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8704243 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17267741 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34968453 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24810798 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23702659 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 29990619 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17293777 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23485472 | ||
| Pubmed | Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. | 8.18e-06 | 2 | 100 | 2 | 17696940 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 8.18e-06 | 2 | 100 | 2 | 10854210 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16150826 | ||
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 8.18e-06 | 2 | 100 | 2 | 23527289 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 8.18e-06 | 2 | 100 | 2 | 22079981 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28986537 | ||
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 8.18e-06 | 2 | 100 | 2 | 9490683 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16481742 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18983515 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34378815 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9482226 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 8.18e-06 | 2 | 100 | 2 | 7586361 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25658374 | ||
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 8.18e-06 | 2 | 100 | 2 | 21239499 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10642175 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12225871 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9770530 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32286604 | ||
| Pubmed | Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. | 8.18e-06 | 2 | 100 | 2 | 10073957 | |
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 8.18e-06 | 2 | 100 | 2 | 30323258 | |
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 8.18e-06 | 2 | 100 | 2 | 37971174 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 8.18e-06 | 2 | 100 | 2 | 26473342 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10816371 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24792713 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 8.18e-06 | 2 | 100 | 2 | 26791370 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 218932 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31922915 | ||
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 8.18e-06 | 2 | 100 | 2 | 32694536 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 7525077 | ||
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 8.18e-06 | 2 | 100 | 2 | 16052596 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17122079 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 16103174 | ||
| Pubmed | Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it. | 8.18e-06 | 2 | 100 | 2 | 2531657 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21300353 | ||
| Pubmed | A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. | 8.18e-06 | 2 | 100 | 2 | 11777956 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15737740 | ||
| Interaction | ZNF397 interactions | 1.34e-05 | 62 | 99 | 5 | int:ZNF397 | |
| Interaction | LPA interactions | 1.84e-05 | 11 | 99 | 3 | int:LPA | |
| Interaction | SCGB1A1 interactions | 2.45e-05 | 12 | 99 | 3 | int:SCGB1A1 | |
| Cytoband | 6q26 | 7.99e-06 | 18 | 100 | 3 | 6q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | DPF1 ZNF875 ETV2 C19orf73 RASIP1 ZNF776 FCGBP ZNF497 MEGF8 ZNF30 | 2.81e-04 | 1192 | 100 | 10 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 5.53e-04 | 16 | 100 | 2 | chr6q26 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF410 ZNF672 ZNF48 SALL3 ZNF337 ZNF875 ZNF184 ZNF316 ZNF407 ZNF213 ZNF275 ZNF619 ZNF467 GFI1 ZNF786 ZXDB ZNF776 ZNF497 ZNF718 GLI4 ZNF84 ZFP92 ZNF30 ZNF697 | 3.06e-16 | 718 | 73 | 24 | 28 |
| GeneFamily | Laminin subunits | 1.35e-05 | 12 | 73 | 3 | 626 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.89e-08 | 196 | 99 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 9.41e-08 | 275 | 99 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.67e-07 | 191 | 99 | 8 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 8.82e-07 | 270 | 99 | 9 | MM17057 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 8.86e-07 | 20 | 99 | 4 | MM17053 | |
| Coexpression | NABA_MATRISOME | COL4A6 FN1 TNC KCP LAMB3 LAMC1 LAMC3 GDF2 THBS3 MEGF8 CLEC14A LPA PLG VWA2 MUC5AC FBN3 | 1.45e-06 | 1026 | 99 | 16 | M5889 |
| Coexpression | NABA_MATRISOME | COL4A6 FN1 TNC KCP LAMB3 LAMC1 LAMC3 GDF2 THBS3 MEGF8 CLEC14A LPA PLG VWA2 MUC5AC | 5.64e-06 | 1008 | 99 | 15 | MM17056 |
| Coexpression | GU_PDEF_TARGETS_UP | 7.42e-06 | 71 | 99 | 5 | M3955 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL | 1.27e-05 | 375 | 99 | 9 | M39162 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.58e-05 | 40 | 99 | 4 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 1.85e-05 | 14 | 99 | 3 | M48002 | |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN | 1.97e-05 | 146 | 99 | 6 | M6341 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A6 RUNDC3B ACTA2 LAMC1 LAMC3 ACSL4 RASIP1 CLEC14A NOTCH3 NOTCH4 | 2.17e-05 | 505 | 99 | 10 | M39167 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 4.26e-05 | 337 | 99 | 8 | M13206 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 4.45e-05 | 440 | 99 | 9 | M39039 | |
| Coexpression | GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 9.91e-05 | 195 | 99 | 6 | M8134 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.43e-04 | 27 | 99 | 3 | M47994 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS | 1.66e-04 | 645 | 99 | 10 | M40158 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.67e-05 | 245 | 97 | 8 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_1000 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-08 | 198 | 100 | 8 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | EC|World / Lineage and Cell class | 2.64e-07 | 192 | 100 | 7 | 478866dd5b0d6ff3a76d07a17c4b5989dd7a27bb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-07 | 193 | 100 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-07 | 195 | 100 | 7 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.04e-07 | 196 | 100 | 7 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-07 | 198 | 100 | 7 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-07 | 198 | 100 | 7 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-07 | 198 | 100 | 7 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-07 | 198 | 100 | 7 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-07 | 199 | 100 | 7 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-06 | 170 | 100 | 6 | 65c7ed586e7615203a59999549892ed466a89502 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.45e-06 | 171 | 100 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.71e-06 | 174 | 100 | 6 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-06 | 177 | 100 | 6 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.51e-06 | 182 | 100 | 6 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 183 | 100 | 6 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 183 | 100 | 6 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-06 | 184 | 100 | 6 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 184 | 100 | 6 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 185 | 100 | 6 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 185 | 100 | 6 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 185 | 100 | 6 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.23e-06 | 188 | 100 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-06 | 188 | 100 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-06 | 189 | 100 | 6 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.36e-06 | 189 | 100 | 6 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-06 | 189 | 100 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 189 | 100 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-06 | 189 | 100 | 6 | 2e43428f1ef9683c6f8c9897d46aa7d34bf9047f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 189 | 100 | 6 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.49e-06 | 190 | 100 | 6 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.49e-06 | 190 | 100 | 6 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 190 | 100 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.49e-06 | 190 | 100 | 6 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-06 | 191 | 100 | 6 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-06 | 191 | 100 | 6 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.63e-06 | 191 | 100 | 6 | 718c83046668a7c33bd8319b45c56f8edb34cfe7 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-06 | 191 | 100 | 6 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | Endothelial-C|World / shred on cell class and cell subclass (v4) | 4.63e-06 | 191 | 100 | 6 | bf203931f973098b79ec681d1dd0854419819e98 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.77e-06 | 192 | 100 | 6 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 192 | 100 | 6 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 192 | 100 | 6 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 192 | 100 | 6 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-06 | 193 | 100 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-06 | 193 | 100 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | droplet-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-06 | 193 | 100 | 6 | 95c9c63bddfed1a84393ccd3578cfe65bc0c1c05 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-06 | 193 | 100 | 6 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.22e-06 | 195 | 100 | 6 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-06 | 197 | 100 | 6 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-06 | 197 | 100 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.53e-06 | 197 | 100 | 6 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-06 | 197 | 100 | 6 | 31bec97c3952c48031bd66a5dad16a70a61519c3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-06 | 197 | 100 | 6 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 198 | 100 | 6 | bfad1c51cf884ff7ce89f8278820800582541dc7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 198 | 100 | 6 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.69e-06 | 198 | 100 | 6 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 198 | 100 | 6 | 6372e65242236c497d9b3be147092897c1609d22 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 198 | 100 | 6 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 198 | 100 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.69e-06 | 198 | 100 | 6 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 198 | 100 | 6 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 5.86e-06 | 199 | 100 | 6 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 5.86e-06 | 199 | 100 | 6 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 199 | 100 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 5.86e-06 | 199 | 100 | 6 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.86e-06 | 199 | 100 | 6 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.03e-06 | 200 | 100 | 6 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.03e-06 | 200 | 100 | 6 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.03e-06 | 200 | 100 | 6 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 6.03e-06 | 200 | 100 | 6 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-05 | 156 | 100 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-05 | 157 | 100 | 5 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.06e-05 | 160 | 100 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.16e-05 | 161 | 100 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.25e-05 | 162 | 100 | 5 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-05 | 169 | 100 | 5 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.09e-05 | 170 | 100 | 5 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.21e-05 | 171 | 100 | 5 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.21e-05 | 171 | 100 | 5 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.32e-05 | 172 | 100 | 5 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.32e-05 | 172 | 100 | 5 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.32e-05 | 172 | 100 | 5 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | 2a5ea28c65dd4ee03ba3d0bfe0c819b1d583f8da | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | 6a7e4fa2d9d00f50decc89b535d8a68ec96de58a | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.57e-05 | 174 | 100 | 5 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| Computational | Neighborhood of BMPR2 | 1.45e-04 | 85 | 64 | 5 | GCM_BMPR2 | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; PC3; HT_HG-U133A | 2.66e-06 | 200 | 99 | 8 | 4677_UP | |
| Drug | kalinin | 4.11e-06 | 55 | 99 | 5 | CID000032518 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.21e-06 | 155 | 99 | 7 | 6817_DN | |
| Drug | AC1L9INI | 5.83e-06 | 59 | 99 | 5 | CID000445839 | |
| Drug | DNOC | 1.59e-05 | 35 | 99 | 4 | CID000010800 | |
| Drug | 3-nitrofluoranthen-6-ol | 1.87e-05 | 2 | 99 | 2 | CID000146572 | |
| Drug | 3-nitrofluoranthen-9-ol | 1.87e-05 | 2 | 99 | 2 | CID000146573 | |
| Drug | 3-nitrofluoranthen-8-ol | 1.87e-05 | 2 | 99 | 2 | CID000146567 | |
| Drug | 1,3,6-trinitropyrene | 1.87e-05 | 2 | 99 | 2 | CID000053229 | |
| Drug | AC1L25J4 | 1.87e-05 | 2 | 99 | 2 | CID000041328 | |
| Drug | 2-methylcarbazole | 1.87e-05 | 2 | 99 | 2 | CID000019290 | |
| Drug | m-nitrobenzamidine hydrochloride | 1.87e-05 | 2 | 99 | 2 | CID000165122 | |
| Drug | 2-nitrobenzofuran | 1.87e-05 | 2 | 99 | 2 | CID000036328 | |
| Drug | 1,3,6,8-tetranitropyrene | 1.87e-05 | 2 | 99 | 2 | CID000034321 | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 5611_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 3769_DN | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; PC3; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 4183_UP | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 3.65e-05 | 373 | 99 | 9 | ctd:C540355 | |
| Drug | anthranilic acid | 4.36e-05 | 89 | 99 | 5 | CID000000227 | |
| Drug | virus Tat | 5.19e-05 | 17 | 99 | 3 | CID000071655 | |
| Drug | Aminocaproic Acid | 5.60e-05 | 3 | 99 | 2 | DB00513 | |
| Drug | pyrazolo(3,4-d)pyrimidine | 6.92e-05 | 98 | 99 | 5 | ctd:C014175 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 7.42e-05 | 161 | 99 | 6 | 3556_DN | |
| Drug | Rgd Peptide | 8.44e-05 | 239 | 99 | 7 | CID000104802 | |
| Drug | nitromethanamine | 1.12e-04 | 4 | 99 | 2 | CID000061148 | |
| Drug | 1-amino-8-nitropyrene | 1.12e-04 | 4 | 99 | 2 | CID000108113 | |
| Drug | methyl p-nitrobenzoate | 1.12e-04 | 4 | 99 | 2 | CID000012083 | |
| Drug | IWR-1 compound | 1.12e-04 | 4 | 99 | 2 | ctd:C585534 | |
| Drug | anilino acetate | 1.12e-04 | 4 | 99 | 2 | CID000153367 | |
| Drug | c0458 | 1.12e-04 | 4 | 99 | 2 | CID009543178 | |
| Disease | non-syndromic X-linked intellectual disability 63 (implicated_via_orthology) | 1.00e-05 | 2 | 94 | 2 | DOID:0112050 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 8.17e-05 | 702 | 94 | 10 | C0009402 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 9.98e-05 | 5 | 94 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | plasma plasminogen measurement | 9.98e-05 | 5 | 94 | 2 | EFO_0006309 | |
| Disease | angiostatin measurement | 1.49e-04 | 6 | 94 | 2 | EFO_0008024 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 1.49e-04 | 6 | 94 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.74e-04 | 34 | 94 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.74e-04 | 34 | 94 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 2.09e-04 | 7 | 94 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.09e-04 | 91 | 94 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | sphingomyelin measurement | 2.70e-04 | 278 | 94 | 6 | EFO_0010118 | |
| Disease | urinary albumin to creatinine ratio | 2.76e-04 | 179 | 94 | 5 | EFO_0007778 | |
| Disease | N-acetylneuraminate measurement | 2.78e-04 | 8 | 94 | 2 | EFO_0020022 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.84e-04 | 40 | 94 | 3 | EFO_0004746 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.52e-04 | 43 | 94 | 3 | EFO_0022290 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 3.56e-04 | 9 | 94 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.30e-04 | 46 | 94 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | cholesterol to total lipids in small HDL percentage | 5.84e-04 | 51 | 94 | 3 | EFO_0022240 | |
| Disease | monokine induced by gamma interferon measurement | 6.18e-04 | 52 | 94 | 3 | EFO_0008236 | |
| Disease | temporal arteritis | 6.49e-04 | 12 | 94 | 2 | EFO_1001209 | |
| Disease | beta wave measurement | 6.49e-04 | 12 | 94 | 2 | EFO_0006871 | |
| Disease | total phospholipids in lipoprotein particles measurement | 6.53e-04 | 53 | 94 | 3 | EFO_0022315 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 6.53e-04 | 53 | 94 | 3 | EFO_0022286 | |
| Disease | triglycerides in medium HDL measurement | 6.90e-04 | 54 | 94 | 3 | EFO_0022321 | |
| Disease | triglycerides in LDL measurement | 7.68e-04 | 56 | 94 | 3 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 7.68e-04 | 56 | 94 | 3 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 7.68e-04 | 56 | 94 | 3 | EFO_0022279 | |
| Disease | low density lipoprotein particle size measurement | 8.51e-04 | 58 | 94 | 3 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small LDL percentage | 8.94e-04 | 59 | 94 | 3 | EFO_0022337 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 9.39e-04 | 60 | 94 | 3 | EFO_0022282 | |
| Disease | free cholesterol in IDL measurement | 9.86e-04 | 61 | 94 | 3 | EFO_0022181 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.03e-03 | 15 | 94 | 2 | EFO_0007804, GO_0036273 | |
| Disease | triglycerides in medium LDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022322 | |
| Disease | free cholesterol in very large HDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022273 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.08e-03 | 63 | 94 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.08e-03 | 63 | 94 | 3 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.13e-03 | 64 | 94 | 3 | EFO_0022253 | |
| Disease | triglycerides in small LDL measurement | 1.19e-03 | 65 | 94 | 3 | EFO_0022323 | |
| Disease | total lipids in very large HDL measurement | 1.24e-03 | 66 | 94 | 3 | EFO_0022312 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.29e-03 | 67 | 94 | 3 | EFO_0022245 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.32e-03 | 17 | 94 | 2 | EFO_0022232 | |
| Disease | free cholesterol in large VLDL measurement | 1.35e-03 | 68 | 94 | 3 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.41e-03 | 69 | 94 | 3 | EFO_0022341 | |
| Disease | cholesterol in very large HDL measurement | 1.41e-03 | 69 | 94 | 3 | EFO_0022229 | |
| Disease | juvenile idiopathic arthritis | 1.72e-03 | 74 | 94 | 3 | EFO_0002609 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.72e-03 | 74 | 94 | 3 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.79e-03 | 75 | 94 | 3 | EFO_0022287 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.01e-03 | 713 | 94 | 8 | EFO_0005689 | |
| Disease | stroke, coronary artery disease | 2.03e-03 | 21 | 94 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | saturated fatty acids to total fatty acids percentage | 2.03e-03 | 21 | 94 | 2 | EFO_0022305 | |
| Disease | Deep Vein Thrombosis | 2.03e-03 | 21 | 94 | 2 | C0149871 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.03e-03 | 21 | 94 | 2 | EFO_0022246 | |
| Disease | Venous Thrombosis | 2.03e-03 | 21 | 94 | 2 | C0042487 | |
| Disease | Glioblastoma | 2.08e-03 | 79 | 94 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.48e-03 | 84 | 94 | 3 | C0334588 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.65e-03 | 24 | 94 | 2 | C0887833 | |
| Disease | Ureteral obstruction | 2.65e-03 | 24 | 94 | 2 | C0041956 | |
| Disease | large artery stroke, coronary artery disease | 2.87e-03 | 25 | 94 | 2 | EFO_0001645, EFO_0005524 | |
| Disease | monocyte count | PRTN3 FN1 DOCK10 GFI1 RSBN1 LPA DUSP16 PLG UBASH3B VWA2 NOTCH4 | 3.18e-03 | 1320 | 94 | 11 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEIIDGKFGCCFSFG | 501 | Q0P6H9 | |
| FCTGDIGEFHPDGCL | 551 | O60488 | |
| LPKCDSGCAETLFGL | 1451 | Q96QE3 | |
| LCLLPFTGFGKCAGI | 31 | Q9H0P7 | |
| GLKGIKGDSGFCACD | 471 | Q14031 | |
| KGDSGFCACDGGVPN | 476 | Q14031 | |
| FATGCGRGAKLPSCA | 436 | O75815 | |
| AGAALGPCPDKCAAF | 196 | Q8NDY6 | |
| FCLGGSKKTGCPEDL | 276 | Q92782 | |
| VCDNGSGLCKAGFAG | 11 | P62736 | |
| KACGCDLAEGGFFVR | 51 | Q6H8Q1 | |
| LLVGGFKCDCPSGDF | 1346 | Q9HCU4 | |
| GCSFLCVFGFPGEKV | 341 | Q96PN6 | |
| GGFECACADGFEPGL | 2146 | Q75N90 | |
| GGPGESSCVDAFALC | 191 | Q5U651 | |
| TIPRGKDGFGFTICC | 301 | P49796 | |
| KDGFGFTICCDSPVR | 306 | P49796 | |
| CKGGCFFPLADDVTP | 356 | Q9UK05 | |
| LGFLCCFGGSDIPEI | 11 | Q86T65 | |
| EPCKNGGTCFDSLDG | 4096 | Q14517 | |
| TGFKPFGCDLCGKGF | 391 | Q99684 | |
| KFGGNCVCRDDPDLG | 81 | O43150 | |
| GCGLTAEDCKDLAFG | 846 | Q9C000 | |
| PGCESICEDFGQFLK | 351 | O15409 | |
| GDLTYDCACLPGFEG | 216 | Q9UM47 | |
| PCFPGDCGIFVTKVD | 646 | Q8TDM6 | |
| CAEGFGGPDCATKLD | 1471 | Q7Z7M0 | |
| GFGDFSCLKICGKDL | 551 | Q12986 | |
| GCSCPGDVAKAFGAG | 221 | Q9P2T1 | |
| VPGGLFSCACATGFK | 2036 | P98164 | |
| GKGFTCECPDDFRTL | 3486 | P98164 | |
| PEFKGRVCGLCGNFD | 1026 | P98088 | |
| GGAFGALDKGCCFED | 26 | A6NEQ2 | |
| AGICFGDSGGPLICD | 196 | P24158 | |
| GDKCVLNFKPCGLFG | 736 | Q9BXW6 | |
| LAGFCCPLGGLAAGK | 11 | Q0VG06 | |
| GLFCDITLCFGGAGG | 91 | Q9NVR0 | |
| CAVGGKSGLFACLDS | 286 | Q9NXS3 | |
| GPADLCGSFCYEVLK | 1556 | Q96BY6 | |
| QGPLKDCIFDLCLGG | 1481 | Q9Y6R7 | |
| SESGFKLLCQCLGFG | 2316 | P02751 | |
| AEFSRCFPGLCEGKS | 126 | Q9BY84 | |
| CFLYFKLGGECVAGP | 491 | Q14534 | |
| TGEKPFACGACGKAF | 346 | P10075 | |
| CQGDSGGPLVCFEKD | 1986 | P08519 | |
| GFQGGGCFRKDALCL | 6 | Q9NVV2 | |
| SEFSKELLGCGCGAG | 426 | O75426 | |
| CDFRGTEGPGCDKAS | 536 | Q13751 | |
| CDRCKDGFFGNPLAP | 861 | P11047 | |
| CCFSPDGKALAVGLN | 1046 | Q05BV3 | |
| GCTCPGDVAKAFGAG | 221 | P36959 | |
| AGLEGAKLGFCFPDL | 21 | O00321 | |
| TGEKPFGCTICGRAF | 1136 | Q9BXA9 | |
| SLCSKILPGFFCDLG | 181 | Q8NH06 | |
| FCLKGEGLDGSFPAV | 201 | Q96NL0 | |
| RCADGGAVGPFKCVF | 31 | Q5VWQ0 | |
| FPALFGDVKFVCVGG | 46 | Q16831 | |
| ELCRKGGFCEELGAP | 246 | Q6NUJ1 | |
| GECGLDFDRLQFCPK | 111 | Q6P1N9 | |
| VGCPLERGFVFDECG | 1481 | Q6ZWJ8 | |
| KTFLCTGFPDGGRDA | 221 | Q7RTZ1 | |
| GFLGADCAKAACPVL | 596 | Q9NT68 | |
| CLPFDEARCGDGGKA | 1336 | Q9NT68 | |
| CQGDSGGPLVCFEKD | 756 | P00747 | |
| GSPLGFICHCPKGFE | 1066 | Q99466 | |
| TGPEFLVGCDCKDGC | 721 | Q15047 | |
| CTGDIGEFEPDGCLK | 561 | O95573 | |
| LGGFACECATGFELG | 266 | Q86T13 | |
| GCCFGTPLGGVLFSI | 276 | P35523 | |
| GEKPFGCEECGKAFS | 256 | P17039 | |
| SGERPFACGDCGKLF | 231 | A6NM28 | |
| LRPFGCPAEGCGKSF | 331 | P98169 | |
| AGEKPFSCEECGNVF | 306 | Q3SXZ3 | |
| KPFGCDVCGKEFARG | 301 | Q96MX3 | |
| GLKPFRCPDCGKSFG | 186 | Q6ZNH5 | |
| ACDLVRGLCKFFEGP | 386 | P55060 | |
| GFPDCENFLLTKCNG | 206 | Q96IC2 | |
| DRSFICPAEGCGKSF | 246 | Q86VK4 | |
| PFKCPECGKGFLESA | 226 | Q499Z4 | |
| CARCSDAVPGGLFGF | 16 | Q8TEQ6 | |
| DGFTGADCGELKCPN | 396 | P24821 | |
| LCPLAFGGEANCALK | 321 | Q5GFL6 | |
| IGCPFAGVGCSFKGS | 86 | Q13077 | |
| FAGTACELCAPGAFG | 2001 | Q9NY15 | |
| TVGSFKCGPCRLGFL | 391 | P49746 | |
| PDCFGKSEGELATCL | 291 | Q3C1V9 | |
| RDIAFGCGNCGKTFP | 231 | P51523 | |
| GAAALRPFACGECGK | 346 | Q5TEC3 | |
| KERPFSCGECGKGFT | 561 | Q8N393 | |
| GCCGVNGPEDFKFAS | 146 | Q96SJ8 | |
| GEKPFVCGVCGAGFS | 771 | A6NFI3 | |
| TGEKPFGCSDCGKSF | 396 | O14771 | |
| PALGEFPFAKCFVCG | 176 | Q8N567 | |
| GDPAGEGKEVLCDFC | 66 | O95361 | |
| KDACFGDSGGPLACN | 231 | Q9Y6M0 | |
| GEKPFVCAECGRGFN | 521 | P10072 | |
| PYLGFCSCEELGETG | 606 | Q8TF42 | |
| TGEKSFLCDLCGFAG | 1681 | Q9C0G0 | |
| CGECGKAFRGPSDLI | 351 | Q9NSD4 | |
| PIQGGDAGELCKCDF | 11 | Q8N2I2 | |
| GPKPFACSDCGLSFG | 351 | Q7Z7K2 | |
| SGEKPFGCNDCGKSF | 721 | Q99676 | |
| GEKPFICSECGQGFI | 596 | Q9Y3M9 | |
| TGERPFECTACGKLF | 371 | Q68DI1 | |
| CEVCDDGFFGDPLGL | 786 | Q9Y6N6 |